| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404686A1 Aryl boronate functionalized polymers for treating obesity |
| 04/07/2004 | EP1404685A1 Aryl boronic acids for treating obesity |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404675A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404649A1 New phenylalkyloxy-phenyl derivatives |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404349A1 Fat-binding polymers |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404338A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404320A2 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404313A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS |
| 04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404306A1 A coated nicotine-containing chewing gum, manufacture and use thereof |
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404178A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 04/07/2004 | EP1185272B1 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts for the treatment of bipolar disorders and mania |
| 04/07/2004 | EP1105123B1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 04/07/2004 | EP1052997B1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperandrogenism and/or anovulation |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0881219B1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 04/07/2004 | EP0559884B2 Viral recombinant vectors for expression in muscle cells |
| 04/07/2004 | CN1487940A Lactam compounds and medicinal use thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487928A Chemical compounds |
| 04/07/2004 | CN1487921A Preparation of non-crystalline at orvastatin calcium |
| 04/07/2004 | CN1487916A Process for the preparation of arylethanoldiamines useful as agonists the beta-3-adrenoceptor |
| 04/07/2004 | CN1487822A Anti-adiposis composition based on garlic bulb extracts |
| 04/07/2004 | CN1486742A Capsule prepn for regulating blood fat and blood sugar |
| 04/07/2004 | CN1486732A Hypoglycemic oral liquid prepn and its production process |
| 04/07/2004 | CN1486730A Capsule prepn for regulating blood fat and blood pressure |
| 04/07/2004 | CN1486729A Medicine for treating and preventing hypertenston and hyperlipemia and its prepn |
| 04/07/2004 | CN1486724A Chinese medicine for treating diabetes |
| 04/07/2004 | CN1486711A Medicine for treating diabetes and its prepn |
| 04/07/2004 | CN1486707A Method of extracting medicine for hyperlipemia from Chinese onion bulb |
| 04/07/2004 | CN1486698A Solid oral preparation containing melbine and Glibenclamide |
| 04/07/2004 | CN1486695A Delayed releasing Acipimox prepn |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144797C Polycyclic thiazolidin-2-ylidene amines, producing process thereof and use as medicine |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/07/2004 | CN1144787C Aryl fused azapolycyclic compounds |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/07/2004 | CN1144585C Animal fast biochemical accelerating composition containing cysteamine and its salt and use |
| 04/06/2004 | US6717008 Use as anorectics, treating obesity and type ii diabetes; c2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group |
| 04/06/2004 | US6716985 Alcoholism, psychological disorders |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal |
| 04/06/2004 | US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716624 GSK3 polypeptides |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716592 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716459 Using plant extract; corosolic acid |
| 04/06/2004 | US6716447 Stable carotene xanthophyll beadlet compositions and methods of use |
| 04/06/2004 | US6716436 In combination with cosmetically acceptable excipient at least one nitric oxide precursor compound which is l-arginine analogue or one of its derivatives or salts |
| 04/06/2004 | CA2404810C Topical composition having undifferentiated plant seed cells and method for using same |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/06/2004 | CA2036592C Therapeutic agent for diabetic gangrene |
| 04/02/2004 | WO2004031372A1 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 04/02/2004 | CA2435274A1 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/01/2004 | WO2004026907A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026816A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | WO2004026322A1 Method and preparation for preventing casualty caused by iodine radionuclides and optimising iodine metabolism in a postprophylaxis period |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |